Literature DB >> 20303725

Trends in bronchiectasis mortality in England and Wales.

Helen J Roberts1, Richard Hubbard.   

Abstract

BACKGROUND: To provide information on the burden of bronchiectasis in England and Wales, we have examined trends in mortality using death certificate data available from the Office of National Statistics.
METHODS: We extracted data on deaths due to non-cystic fibrosis bronchiectasis for 2001-2007 inclusive and stratified deaths by sex and age group. We used Poisson regression to compare mortality rates.
RESULTS: Between 2001 and 2007, 5745 bronchiectasis related deaths were registered in England and Wales. When standardized to the 2007 population, this showed a rise in absolute numbers from 797 (2001) to 908 (2007). Statistical analyses suggested that the mortality rate is currently increasing at 3%/year (p < 0.001). Mortality rates were similar between men and women but there was a strong statistical interaction between age group and year (p < 0.001) Rates were increasing in the two oldest age groups but falling in the three youngest groups. DISCUSSION: Currently just under 1000 people die from bronchiectasis each year in England and Wales. We found the number of deaths to be increasing at 3% per year. Although overall mortality was increasing, rates were increasing in older groups but falling in the younger groups. These mortality rates may underestimate the burden of disease from bronchiectasis as lack of knowledge about the disease may lead to underreporting. These are also mortality rather than incidence data and may reflect improvements in treatment. Bronchiectasis therefore remains a significant concern. Clinical provision will potentially need to increase in order to care for this patient group. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20303725     DOI: 10.1016/j.rmed.2010.02.022

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  40 in total

Review 1.  Non Cystic Fibrosis Bronchiectasis.

Authors:  Anand K Gupta; Rakesh Lodha; Sushil K Kabra
Journal:  Indian J Pediatr       Date:  2015-08-27       Impact factor: 1.967

Review 2.  Interventions for bronchiectasis: an overview of Cochrane systematic reviews.

Authors:  Emma J Welsh; David J Evans; Stephen J Fowler; Sally Spencer
Journal:  Cochrane Database Syst Rev       Date:  2015-07-14

Review 3.  Positive expiratory pressure therapy versus other airway clearance techniques for bronchiectasis.

Authors:  Annemarie L Lee; Angela T Burge; Anne E Holland
Journal:  Cochrane Database Syst Rev       Date:  2017-09-27

Review 4.  Bronchiectasis in older patients with chronic obstructive pulmonary disease : prevalence, diagnosis and therapeutic management.

Authors:  Deborah Whitters; Robert A Stockley
Journal:  Drugs Aging       Date:  2013-04       Impact factor: 3.923

5.  Could vitamin d have a potential anti-inflammatory and anti-infective role in bronchiectasis?

Authors:  Jim Bartley; Jeff Garrett; Cameron C Grant; Carlos A Camargo
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

6.  Prognostic Factors in Adult Patients with Non-Cystic Fibrosis Bronchiectasis.

Authors:  Betina Charvet Machado; Patrícia Santos Jacques; Louise Piva Penteado; Paulo de Tarso Roth Dalcin
Journal:  Lung       Date:  2018-09-25       Impact factor: 2.584

7.  Critical care admission trends and outcomes in individuals with bronchiectasis in the UK.

Authors:  Vidya Navaratnam; Colin R Muirhead; Richard B Hubbard; Anthony De Soyza
Journal:  QJM       Date:  2015-11-17

8.  Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial.

Authors:  Anne B Chang; Keith Grimwood; Colin F Robertson; Andrew C Wilson; Peter P van Asperen; Kerry-Ann F O'Grady; Theo P Sloots; Paul J Torzillo; Emily J Bailey; Gabrielle B McCallum; Ian B Masters; Catherine A Byrnes; Mark D Chatfield; Helen M Buntain; Ian M Mackay; Peter S Morris
Journal:  Trials       Date:  2012-08-31       Impact factor: 2.279

9.  Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial.

Authors:  Patricia C Valery; Peter S Morris; Keith Grimwood; Paul J Torzillo; Catherine A Byrnes; I Brent Masters; Paul A Bauert; Gabrielle B McCallum; Charmaine Mobberly; Anne B Chang
Journal:  BMC Pediatr       Date:  2012-08-14       Impact factor: 2.125

10.  Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study.

Authors:  Jennifer K Quint; Elizabeth R C Millett; Miland Joshi; Vidya Navaratnam; Sara L Thomas; John R Hurst; Liam Smeeth; Jeremy S Brown
Journal:  Eur Respir J       Date:  2015-11-05       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.